|
|
 |
|
Viewing report
|
|
|
|
U.S. Diabetes Delivery Systems Markets
Frost & Sullivan, Aug 2001
Planning Implementation Challenge Identification New Pump Designs Spark Interest, Propel Market Growth
As more Americans develop diabetes, markets for insulin delivery devices will remain strong. New insulin pump designs, which are inconspicuous and can be used to tailor treatment to each patient's needs, should help doctors ensure patient compliance to insulin regimens. Although these devices are often cost prohibitive for users, pumps recently received Medicare reimbursement for
Type I diabetics. Consequently, the infusion pump segment is expected to lead market growth over the forecast period.
This Frost & Sullivan research analyzes the markets for insulin infusion pumps, injection pens, and syringes. It examines market drivers and restraints, discusses pricing trends and reimbursement policies, and offers expert revenue forecasts for each segment. With such an informative tool at your fingertips, your company will be poised to realize its full potential.
Increasing Patients' Awareness Should Generate Demand for Injection Pens
Non-insulin pre-filled needle injection pens are excellent devices but are experiencing low growth rates due to their cost and a lack of familiarity with their advantages, observes the study's author. Currently, the majority of injection pen users are newly diagnosed diabetics. Though syringe users might be willing to switch to these versatile devices, manufacturers must educate the target population about the benefits of using these pens.
To overcome cost concerns, manufacturers should emphasize the long-term cost savings of injection pens over syringes and pumps. This research identifies
emerging challenges and presents effective strategic recommendations, helping your firm anticipate and overcome hurdles that may lay ahead.
Syringe Segment Maintains Fragile Hold on Market Share
Insulin syringes have the largest patient base, holding greater than 90 percent of the total patient market share, says the author of this research. Nevertheless, revenue growth for the syringe market is small from year to year. Newly diagnosed diabetics are more likely to adopt injection pen or infusion pump technologies than use syringes.
Patients' aversion to needles and the appeal of less noticeable pumps or pens could contribute to the long-term decline of the syringe market. Although the large patient base will continue to bring in revenues, ultimately participants might find better prospects in emerging technologies. This study evaluates the
interactions between all three major segments, presenting your company with a comprehensive view of the marketplace.
Additional Information
Market Participants
Animas Corp.
Becton, Dickinson, and Co.
Bioject, Inc.
Disetronic Medical Systems, Inc.
Eli Lilly and Co.
Equidyne Systems, Inc.
Infusaid, Inc.
Kendall Healthcare Products
Medi-Ject Corp.
Medisense/Abbott Laboratories
MiniMed, Inc.
Novo Nordisk Pharmaceuticals, Inc.
Qualitest Pharmaceuticals, Inc.
Seimens
Terumo Medical Corp.
Vitajet Corp.
Distributors
Diabetes Equipment and Referral Service
Diabetes Home Care
Diabetic Promotions
Elite Home Medical Supplies
Home Medical of America
Insulin Infusion Specialties, Inc.
Pumps It, Inc.
Wolf Medical Supply, Inc.
Organization
American Diabetes Association
Diabetes Interview
Diabetes Net
Insulin Pumpers
National Institute of Diabetes and Digestive
and Kidney Diseases
Customers who bought this item also bought
European Insulin Delivery Devices Market
US Insulin Delivery Devices: Patient Acceptance Drives Demand
Insulin Delivery Devices Market Analysis and Future Forecast
Insulin Delivery Systems Market Analysis (2007-2010)
U.S. Emerging Insulin Delivery Technologies Markets
Competitor Analysis: Insulin
U.S. Diabetes Insulin Delivery System Markets
The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market
Insulin Delivery Systems Market Analysis (2008-2012)
Insulin Pumps Pipeline Technology And Market Forecasts To 2015
Insulin Pumps (External) - A World Market Review
Insulin Pumps (External) - Global Strategic Business Report
|
|
|
|
